2025 annual financial data
CG Oncology 2025 Operating margin
CG Oncology 2025 operating margin with verified reported values.
Direct answer
Operating margin was -4,722.13%.
Operating income was -190,774,000 USD and net income was -160,995,000 USD.
Operating cash flow was -132,346,000 USD.
Get free CG Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,040,000 USD
- Operating income
- -190,774,000 USD
- Net income
- -160,995,000 USD
- Operating cash flow
- -132,346,000 USD